NIH-funded research R01 grant

Investigating how neutrophil extracellular traps affect inflammatory bowel disease

Official title: Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease

Funded at University of Toledo Health Sci Campus · NIH-11019711 · Data updated 2026-11-12

This study is looking at how a certain enzyme affects the immune response in people with inflammatory bowel disease (IBD), like Crohn's Disease and Ulcerative Colitis, to help find new ways to improve gut health and treatment options.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Toledo Health Sci Campus
NIH-funded
Lab location1 site (Toledo, United States)
Project startFebruary 15, 2023
Project endJanuary 31, 2027
Funding year2025
Award (this year)$430,127
NIH project number5R01DK134053-03
Project IDNIH-11019711 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with inflammatory bowel disease, including Crohn’s Disease and Ulcerative Colitis.

Less likely to help

Patients with other gastrointestinal disorders not classified as inflammatory bowel disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of neutrophil extracellular traps (NETs) in inflammatory bowel disease (IBD), which includes conditions like Crohn’s Disease and Ulcerative Colitis. The study will explore how a specific enzyme, peptidyl arginine deiminase-4 (PAD4), influences the release of NETs and their impact on gut health. By using murine models, the research aims to uncover the molecular mechanisms behind PAD4's role in inflammation and tissue repair in the gastrointestinal tract. Patients may benefit from insights that could lead to new therapeutic strategies for managing IBD.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve the management of inflammatory bowel disease.

How similar studies have gone: While the role of NETs in inflammation is being explored, this specific investigation into PAD4's function in IBD is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Toledo Health Sci Campus
    Toledo, United States
    Active

Researchers

  • Principal investigator: Vijay-Kumar, Matam — University of Toledo Health Sci Campus
  • Study coordinator: Vijay-Kumar, Matam

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.